Global Biopharmaceutical Excipients Market 2023-2029
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global biopharmaceutical excipients market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the excipient, biologics, scale of operation, end user, and region. The global market for biopharmaceutical excipients can be segmented by excipient: bulking agents, solubilizers & surfactants, buffering & tonicity agents, others. The bulking agents segment held the largest share of the global biopharmaceutical excipients market in 2022 and is anticipated to hold its share during the forecast period. Biopharmaceutical excipients market is further segmented by biologics: monoclonal antibodies, vaccines, others. Globally, the monoclonal antibodies segment made up the largest share of the biopharmaceutical excipients market. Based on scale of operation, the biopharmaceutical excipients market is segmented into: commercial, research. The commercial segment was the largest contributor to the global biopharmaceutical excipients market in 2022. On the basis of end user, the biopharmaceutical excipients market also can be divided into: pharma & biotech companies, cmos & cdmos, academic & research institutes, others. The pharma & biotech companies segment is estimated to account for the largest share of the global biopharmaceutical excipients market. Biopharmaceutical excipients market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.
By excipient: bulking agents, solubilizers & surfactants, buffering & tonicity agents, others
By biologics: monoclonal antibodies, vaccines, others
By scale of operation: commercial, research
By end user: pharma & biotech companies, cmos & cdmos, academic & research institutes, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The report also provides a detailed analysis of several leading biopharmaceutical excipients market vendors that include Merck KGaA, Avantor Inc., BASF SE, Evonik Industries AG, Roquette Frres SA, Associated British Foods plc, Ashland Global Holdings Inc., Clariant AG, Fuji Chemical Industry Co., Ltd., Dow Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Scope of the Report
To analyze and forecast the market size of the global biopharmaceutical excipients market.
To classify and forecast the global biopharmaceutical excipients market based on excipient, biologics, scale of operation, end user, region.
To identify drivers and challenges for the global biopharmaceutical excipients market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global biopharmaceutical excipients market.
To identify and analyze the profile of leading players operating in the global biopharmaceutical excipients market.
Why Choose This Report
Gain a reliable outlook of the global biopharmaceutical excipients market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
Objectives of the study
Years considered for the report
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
PART 5. MARKET BREAKDOWN BY EXCIPIENT
Solubilizers & surfactants
Buffering & tonicity agents
PART 6. MARKET BREAKDOWN BY BIOLOGICS
PART 7. MARKET BREAKDOWN BY SCALE OF OPERATION
PART 8. MARKET BREAKDOWN BY END USER
Pharma & biotech companies
Cmos & cdmos
Academic & research institutes
PART 9. MARKET BREAKDOWN BY REGION
MEA (Middle East and Africa)
PART 10. KEY COMPANIES
Evonik Industries AG
Roquette Frres SA
Associated British Foods plc
Ashland Global Holdings Inc.
Fuji Chemical Industry Co., Ltd.
Global Infectious Disease Testing Market Shares
2023 Global Infectious Disease Testing Market Shares in the US, Europe, and Japan--Competitive Analysis of Leading and Emerging Market Players This new report provides infectious diseases testing market shares forView Report
Global Virology Bacteriology Parasitology and Mycology Testing Market in the US Europe and Japan
2023 Global Virology, Bacteriology, Parasitology and Mycology Testing Market in the US, Europe and Japan--2022 Supplier Shares by Test, 2022-2027 Segmentation Forecasts for 100 Respiratory, STD, Enteric, and other MicrobiologyView Report
Global Biopharmaceutical Fermentation Market 2023-2029
Biopharmaceutical fermentation is a bioprocess used to produce pharmaceutical products using living cells, such as bacteria or yeast, as production hosts. The process involves growing these cells in a controlledView Report
Global Biopharmaceutical Contract Manufacturing Market 2022-2028
The global biopharmaceutical contract manufacturing market market is projected to rise by USD 9 billion by 2028, according to a new report by Gen Consulting Company. It is anticipated toView Report
Fill The Form For Sample Request